| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $763.6M | +15.2% |
| Cost of Revenue | $455.7M | +12.6% |
| Gross Profit | $307.9M | +19.1% |
| R&D Expense | $121.9M | +5.3% |
| SG&A Expense | $141.8M | +6.6% |
| Operating Income | $64.8M | -21.7% |
| Interest Expense | $418K | -0.7% |
| Pre-tax Income | $79.4M | -11.0% |
| Income Tax | $9.8M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.7M | +7.3% |
| Accounts Receivable | $104.3M | +1.3% |
| Inventory | $101.7M | -9.0% |
| Current Assets | $605.1M | +5.5% |
| Total Assets | $1.15B | +3.6% |
| Current Liabilities | $131.3M | +0.2% |
| Long-term Debt | $13.3M | -7.5% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $117.5M | +81.9% |
| Capital Expenditures | $38.4M | -31.4% |
| Investing Cash Flow | -$33.5M | -215.3% |
| Financing Cash Flow | -$64.6M | -184.5% |
| Free Cash Flow | $79.1M | +822.4% |
| +42.4% |
| Net Income | $69.6M | -15.5% |
| EPS (Basic) | $0.90 | -15.1% |
| EPS (Diluted) | $0.89 | -15.2% |
| Total Liabilities |
| $198.4M |
| +0.2% |
| Stockholders' Equity | $947.8M | +4.3% |